Search

Your search keyword '"Vercelletto M"' showing total 177 results

Search Constraints

Start Over You searched for: Author "Vercelletto M" Remove constraint Author: "Vercelletto M"
177 results on '"Vercelletto M"'

Search Results

1. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

3. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimerʼs and Parkinsonʼs diseases

5. Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimerʼs disease

6. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

7. Démence sémantique : réflexions d’un groupe de travail pour des critères de diagnostic en français et la constitution d’une cohorte de patients

8. Correction to:A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

9. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

10. Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

14. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

15. Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

18. Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

19. Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers

21. CXCR4involvement in neurodegenerative diseases

22. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

23. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer’s and Parkinson’s diseases

24. Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies

25. Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

26. Immune-related genetic enrichment in frontotemporal dementia

27. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia

28. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases

29. Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia

32. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

33. EHT0202 in Alzheimers Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study

34. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

35. Frontotemporal dementia and its subtypes: A genome-wide association study

36. Frontotemporal dementia and its subtypes: A genome-wide association study

40. Frequency and Phenotypes Associated with C9ORF72 Repeat Expansion in French FTLD and FTLD-ALS Patients (S54.003)

41. Fréquence et phénotypes associés aux mutations du gène c9orf72 dans une cohorte française de patients atteints de DLFT

50. Brain SPECT perfusion of frontotemporal dementia associated with motor neuron disease

Catalog

Books, media, physical & digital resources